Navigation Links


Adnexus in Medical News

I-Therapeutix, Inc. Closes $15 Million Financing

...agement, more than 20 investment professionals, and current investments in more than 115 companies. Polaris-backed successes in life sciences include adnexus (sold to Bristol-Myers Squibb), Advanced Inhalation Research (sold to Alkermes), Alnylam Pharmaceuticals (ALNY), Glycofi (sold to Merck), Momenta Phar...

Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007

...viously announced Productivity Transformation Initiative, $230 million for acquired in-process research and development relating to the acquisition of adnexus and $275 million relating to an impairment of the company's investment in certain auction rate securities (ARS). As of December 31, 2007, the compan...

Biotech Finishes on a High in August, Burrill Report Says

... midpoint of the proposed $14-$16 price range. Its shares jumped 10.8% by the end of August. Eight companies added themselves to the IPO runway: -- adnexus Therapeutics, which is focused on discovering, developing, and commercializing the proprietary drug class called Adnectins. Adnexus' first pr...
Adnexus in Medical Technology

Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322

...ncology in the United States, and in February 2007 adnexus announced interim results of an ongoing Phase 1 op...lerates Adnectin drug discovery and development. adnexus is the exclusive developer of Adnectins. adnexus solely owns the Adnectin patent estate that contro...
Adnexus in Biological Technology

Bristol-Myers Squibb to Acquire Adnexus Therapeutics

Bristol-Myers Squibb to Advance Biologics Strategy Through Targeted Biologics Acquisition PRINCETON, N.J. and WALTHAM, Mass., Sept. 24 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) and Adnexus(TM) Therapeutics announced today the companies have ...

Accuri Cytometers Completes $4 Million Series D Financing

...leantech. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, Helicos Biosciences, Hypnion, IDEXX, ...

Microbia, Inc. Names Alex Chu as Vice President of Process Development

...perience in bioprocess development and manufacturing to Microbia. He was most recently the vice president of manufacturing and process development at adnexus Therapeutics, Bristol-Myers Squibb. Prior to this, he held multiple scientific and management positions at Abbott Laboratories and Abbott BioResearch ...

Accuri Cytometers Completes $13 Million Series C Financing

...Cleantech. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, Helicos Biosciences, Hypnion, IDEXX, ...

Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team

...Irvine and his B.A. in Computer Science and Biochemistry from the University of California, Los Angeles. Dr. John Mendlein recently served as CEO of adnexus Therapeutics (a developer of a new class of protein therapeutics) from May 2005 until October 2007, at which time the privately-held, Boston based bio...

Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community

...n BioPharma company, Bristol-Myers Squibb seeks to reallocate resources to enable additional strategic acquisitions, such as the recent acquisition of adnexus Therapeutics, as well as pursue partnerships and other collaborative arrangements. These alliances should add to the company's innovative capabilities...
Other TagsSclerosiSclerosiSclerosiSclerosiSkiSkiSkiSkiSkiSkiSki
(Date:11/27/2009)...v. 27 Allrecipes.com , the worl...g traffic numbers, with more than 2.8 million visi...r picture of what was served on the biggest food h...in 2009 weighed in at 2,225 calories per serving, ...ding to the Allrecipes site, Sweet Potato Pie I ...
(Date:11/27/2009)...nufacturers who use medical load cells at the hear... by bringing in technology partner Flintec early i...tive medical manufacturers are calling in Flintec ...ojects, ensuring that progress will not be constra...utdated technology. , (PR...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
(Date:11/26/2009)... lead to strains or worse , , THURSDAY, ...rong with stuffing your turkey full to bursting, b...ur suitcase as you pack for holiday trips. , Mo... hospital emergency rooms, doctors, offices, clini...d injuries, such as muscle strains, pulls and tear...
(Date:11/26/2009)... of the Live Life Again Center, a practice offerin...wing number of physicians who are taking advantag...th individuals who are interested in surgical weig... is utilizing Facebook to share before-and-after p...community. , Dallas, TX (...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
(Date:11/23/2009)...-- More than 160 participants gathered this week f...RES INITIATIVE conference. This year,s topic, "Syn...neers, and medical researchers to explore the engi... the emerging field of synthetic biology. , Bonn...rinceton University and this year,s conference cha...
(Date:11/23/2009)...l. A new study provides "incontrovertible evidenc... island of Sumatra about 73,000 years ago deforest...e epicenter, researchers report. , The volcano e...to the atmosphere, leaving a crater (now the world...ong and 35 kilometers wide. Ash from the event has...
(Date:11/23/2009)...f. - By producing some of the highest resolution i...cientists have a deeper understanding how biomolec... may lead to a new treatment for kidney stones usi...n the Nov. 23 online edition of the journal Proce...res how peptides interact with mineral surfaces by...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3ForteBio Launches Dip and Read 28TM 29 Immunogenicity Assay Kit for Rapid Detection of Anti Drug Antibodies 57340 1ForteBio Launches Dip and Read 28TM 29 Immunogenicity Assay Kit for Rapid Detection of Anti Drug Antibodies 57340 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4Pesticides Linked to Parkinsons 57331 1Pesticides Linked to Parkinsons 57331 2
Other Contentsreclusebrownbrownbrownbrownbrownbrownbronchospasmbruisebruisingbruisingspraysspraysspraysbugbugbugbug